Expensive and lengthy clinical trials can delay regulatory evaluation and add significant burden that stifles innovation affecting patient access to novel, high-quality imaging technologies. In silico imaging holds promise for evaluating the safety and effectiveness of imaging technologies with much less burden than clinical trials. We define in silico imaging as a computer simulation of an entire imaging system (including source, object, task, and observer components) used for research, development, optimization, technology assessment, and regulatory evaluation of new technology. In this work we describe VICTRE (our study of virtual imaging clinical trials for regulatory evaluation) and the considerations for building an entire imaging pipeline in silico including device (physics), patient (anatomy, disease), and image interpretation models for regulatory evaluation using open-source tools.
Aldo Badano, Andreu Badal, Stephen Glick, Christian G. Graff, Frank Samuelson, Diksha Sharma, and Rongping Zeng, "In silico imaging clinical trials for regulatory evaluation: initial considerations for VICTRE, a demonstration study," Proc. SPIE 10132, Medical Imaging 2017: Physics of Medical Imaging, 1013220 (Presented at SPIE Medical Imaging: February 16, 2017; Published: 9 March 2017); https://doi.org/10.1117/12.2255746.
Conference Presentations are recordings of oral presentations given at SPIE conferences and published as part of the conference proceedings. They include the speaker's narration along with a video recording of the presentation slides and animations. Many conference presentations also include full-text papers. Search and browse our growing collection of more than 14,000 conference presentations, including many plenary and keynote presentations.
Study of self-shadowing effect as a simple means to realize nanostructured thin films and layers with special attentions to birefringent obliquely deposited thin films and photo-luminescent porous silicon